Aptamer Group and Bio-Works Technologies have entered into an agreement to develop an affinity resin for improved purification and scale up of gene therapy vectors.  Under the agreement, Aptamer Group will develop an Optimer ligand capable of binding and eluting of a viral vector. Bio-Works Technologies will then develop a derivatised resin by coupling the Optimer to its patented WorkBeads agarose beads.  Optimer ligands […]